Exploring Naturally Tailored Bacterial Outer Membrane Vesicles for Selective Bacteriostatic Implant Coatings
Advanced Science · 2024
DOI: 10.1002/advs.202405764 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Zilin Zhou und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, C…. Hauptthemen laut MEDLINE: Bacterial Outer Membrane, Anti-Bacterial Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Sichuan Province, Chengdu Science and Technology Support Program.
Abstract (Originalsprache)
In treating infectious diseases, achieving selective bacterial inhibition is crucial for preserving the microecological equilibrium. The current approaches predominantly rely on synthetic materials tailored to specific bacteria, considering their cell walls or oxygen requirements. Herein, inspired by intricate bacterial communication, a natural implant is proposed coating utilizing bacterial outer membrane vesicles (OMVs), essential components in bacterial signaling, integrated onto diverse implant surfaces through a universal poly (tannic acid) bridging layer. This coating is homogenous and stable, unexpectedly promoting the proliferation of parental bacteria while inhibiting heterologous bacteria both in vitro and in vivo. Through high‐throughput sequencing and bioinformatics analysis, the selective bacteriostatic ability arises from OMVs, upregulating anti‐oxidative stress genes in heterologous bacteria and activating biofilm‐related genes in parental bacteria. This study positions OMVs as an appealing biomaterial for selective bacterial inhibition through a biological approach, showcasing their potential in regulating the microecological balance through a natural interface modification strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, P. R. China.
- Department of Cariology and Endodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, P. R. China.
- Department of Jinjiang Outpatient, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, P. R. China.
- College of Polymer Science and Engineering, State Key Laboratory of Polymer Materials Engineering, Sichuan University, Chengdu, 610065, P. R. China.
- Med-X Center for Materials, Sichuan University, Chengdu, 610065, P. R. China.
ORCID-Profile: Jiaojiao Yang
Förderung
- National Natural Science Foundation of China
- Key Research and Development Program of Sichuan Province
- Chengdu Science and Technology Support Program
- Postdoctoral Foundation of Sichuan University Grant
- Postdoctoral Cross Funding of Sichuan University
- China Postdoctoral Foundation
Zitieren
APA
Zhou, Z., Sun, L., Tu, Y., Yang, Y., Hou, A., Li, J., Luo, J., Cheng, L., Li, J., Liang, K., & Yang, J. (2024). Exploring Naturally Tailored Bacterial Outer Membrane Vesicles for Selective Bacteriostatic Implant Coatings. Advanced Science. https://doi.org/10.1002/advs.202405764
Vancouver
Zhou Z, Sun L, Tu Y, Yang Y, Hou A, Li J, et al. Exploring Naturally Tailored Bacterial Outer Membrane Vesicles for Selective Bacteriostatic Implant Coatings. Advanced Science. 2024. doi:10.1002/advs.202405764
BibTeX
@article{Zhou2024,
author = {Zhou, Zilin and Sun, Lizhong and Tu, Yuanyuan and Yang, Yingming and Hou, Ailin and Li, Jiyao and Luo, Jun and Cheng, Lei and Li, Jianshu and Liang, Kunneng and Yang, Jiaojiao},
title = {Exploring Naturally Tailored Bacterial Outer Membrane Vesicles for Selective Bacteriostatic Implant Coatings},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202405764}
}
EUVIMED